hVIVO runs both human challenge studies and conventional early phase trials. It traces its origins to Retroscreen Virology, founded out of Queen Mary University once the Common Cold Unit had closed, and it later merged with Venn Life Sciences, which brought drug development consultancy along with clinical trial design and execution. Volunteer recruitment runs through its own UK and German units: FluCamp recruits healthy volunteers in the UK for human challenge trials, while CRS enrols volunteers and patients in Germany for Phase I to III studies.
hVIVO operates as an integrated drug development partner uniting clinical sites, laboratories, human challenge expertise and consulting, with capabilities spanning respiratory and infectious disease, cardiometabolic areas and large human challenge facilities. It works with global biopharmaceutical and emerging biotechnology companies, and its flagship Canary Wharf site houses quarantine bedrooms, laboratories and an outpatient unit.